|
| Human CLEC10A Protein (LTP10331) |
|
| LTP10331 |
|
| 100ug |
|
|
$406 In stock |
| CLEC10A, (C-type lectin domain family 10, member A), as the member of C-type lectin receptors (CLRs), plays a vital role in modulating innate immunity and adaptive immunity and has shown great potential as an immunotherapy target for cancers. However, there is no functional research of CLEC10A in prognostic risk, immunotherapy or any other treatment of lung adenocarcinoma (LUAD). |
| Recombinant Human CLEC10A Protein is expressed from Expi293 with His tag at the C-terminal. It contains Gln61-Ser316. |
|
| CLEC10A |
|
| Human |
|
| Q8IUN9-1 |
|
| Gln61-Ser316 |
|
| The protein has a predicted MW of 29.7 kDa. Due to glycosylation, the protein migrates to 38-45 kDa based on the Tris-Bis PAGE result. |
|
| 0 |
|
| C-His |
|
| Expi293 |
|
| > 95% as determined by Tris-Bis PAGE; > 95% as determined by HPLC |
|
| Less than 1EU per ug by the LAL method. |
|
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as a protectant before lyophilization. |
|
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
|
| Shipped at ambient temperature. |
|
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
|
|  |
